Early Low‐Dose Rituximab for Mild‐to‐Moderate Thyroid Eye Disease: A Preliminary Evaluation of Efficacy and Safety

International Journal of Endocrinology · Published 2026-01-01 · DOI 10.1155/ije/9495296

Free full text

Authors being retrieved — see the publisher record. https://doi.org/10.1155/ije/9495296

Abstract

DOAJ holds no abstract for this record.

Read the article at the publisher →

Publication details

Year
2026

Related articles